-Innovative CHROMA stent platform with cobalt chromium alloy

-Strut thickness only 84um

-Classic rapamycin

-Optimized drug dosage

-Potential faster healing process without affecting restenosis rate

-Unique formulated biodegradable polylactic acid(PLA) coating as drug carrier, which will degrade completely into CO2&H2O in 6-9 month with reduced chronic inflammatory reactions

-Effective reduction of the risk of in-stent ST/VLST

-Targeted drug release via abluminal biodegradable coating

-Larger side branch access with better operation experience

-More complete specifications and sizes give clinicians more better selections